Home / Resource Library / T-cell dysregulation informs radiotherapy-immunotherapy response in B-cell lymphoma: results from a Phase I trialT-cell dysregulation informs radiotherapy-immunotherapy response in B-cell lymphoma: results from a Phase I trial